CytomX Therapeutics, Inc. (CTMX)

NASDAQ

$2.51

$-0.00

(-0.12%)

Pre-Market

CytomX Therapeutics, Inc. (CTMX) Live Price Chart

Last updated: ⁦2026-10-21 11:37:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

CytomX Therapeutics, Inc. (CTMX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.51, with a market capitalization of $509.88M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.20 to $8.21. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$509.88M
Open	$2.51
Day's High	$35.00
Day's Low	$0.40
Previous Close	$2.51
Volume	150.82K
Average Volume	3.27M
P/E Ratio	--
52-Week High	$8.21
52-Week Low	$2.20
Dividend Yield	--
Earnings Date	--

CytomX Therapeutics, Inc. (CTMX) Pre-Market Stock Price

CytomX Therapeutics, Inc. (CTMX) is trading at $2.51 in pre-market trading as of 2026-10-21 10:58:00, unchanged from the previous close of $2.51

Pre-market trading shows how investors are pricing CTMX before the regular session opens. The current pre-market price is near the previous close, indicating neutral early trading sentiment.

CytomX Therapeutics, Inc. (CTMX) 7-Day Stock Price Change

Over the past seven days, CytomX Therapeutics, Inc. (CTMX) moved from $2.42 to $2.51, representing a gain of 3.72% ($0.09).

The stock traded between $2.20 and $2.58 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 3.56 million shares, up versus the previous seven-day period, indicating higher trading activity.

CTMX 52-Week Price Position

Position in Range: 5.2%

52W Low$2.20

52W High$8.21

CTMX is currently trading at $2.51, placing it 5.2% of the way from its 52-week low of $2.20 to its 52-week high of $8.21. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is CytomX Therapeutics, Inc. (CTMX)?

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

CytomX Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	69
Exchange	NASDAQ
Company Website	https://www.cytomx.com

How to Buy CytomX Therapeutics, Inc. (CTMX) Stock on MEXC

Eligible investors can buy real shares of CytomX Therapeutics, Inc. (CTMX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CTMX and Place Your Order

Open the RealStocks trading page and search for CTMX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is CytomX Therapeutics, Inc. (CTMX) stock price today?

CytomX Therapeutics, Inc. (CTMX) is currently trading at $ 2.51, unchanged from the previous close of $ 2.51. Intraday prices update in real time during regular trading hours.

2.Is CTMX stock going up or down today?

As of 2026-10-21 10:58:00, CTMX is trading at $ 2.51, unchanged from its previous close of $ 2.51. The stock has traded between $ 0.40 and $ 35.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is CTMX pre-market price?

As of 2026-10-21 10:58:00, CTMX is trading at $ 2.51 in pre-market trading, unchanged from the previous close of $ 2.51. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CTMX after-hours price?

As of 2026-10-21 10:58:00, CTMX is trading at $ 2.51 in after-hours trading, up 0.04% ($0.00) from the regular-session close of $ 2.51. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CTMX stock trading now?

CTMX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CTMX sit relative to its 52-week high and low?

Over the past 52 weeks, CTMX has traded between a low of $ 2.20 and a high of $ 8.21. At $ 2.51, the stock is positioned 5.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is CytomX Therapeutics, Inc. in?

CytomX Therapeutics, Inc. (CTMX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is CytomX Therapeutics, Inc.'s market capitalization and where is it listed?

CytomX Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 509.88M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CTMX valued in terms of P/E ratio and EPS?

CTMX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.38. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does CytomX Therapeutics, Inc. pay a dividend?

CytomX Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.